Global Brucellosis Vaccines Market Insights and Forecast to 2028

Report ID: 1229313 | Published Date: Jan 2025 | No. of Page: 115 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Brucellosis Vaccines Product Introduction
    1.2 Market by Type
        1.2.1 Global Brucellosis Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 S19 Vaccine
        1.2.3 RB51 Vaccine Strain
    1.3 Market by Application
        1.3.1 Global Brucellosis Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Cattle
        1.3.3 Sheep
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Brucellosis Vaccines Sales Estimates and Forecasts 2017-2028
    2.2 Global Brucellosis Vaccines Revenue Estimates and Forecasts 2017-2028
    2.3 Global Brucellosis Vaccines Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Brucellosis Vaccines Sales by Region
        2.4.1 Global Brucellosis Vaccines Sales by Region (2017-2022)
        2.4.2 Global Sales Brucellosis Vaccines by Region (2023-2028)
    2.5 Global Brucellosis Vaccines Revenue by Region
        2.5.1 Global Brucellosis Vaccines Revenue by Region (2017-2022)
        2.5.2 Global Brucellosis Vaccines Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Brucellosis Vaccines Sales by Manufacturers
        3.1.1 Global Top Brucellosis Vaccines Manufacturers by Sales (2017-2022)
        3.1.2 Global Brucellosis Vaccines Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Brucellosis Vaccines in 2021
    3.2 Global Brucellosis Vaccines Revenue by Manufacturers
        3.2.1 Global Brucellosis Vaccines Revenue by Manufacturers (2017-2022)
        3.2.2 Global Brucellosis Vaccines Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Brucellosis Vaccines Revenue in 2021
    3.3 Global Brucellosis Vaccines Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Brucellosis Vaccines Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Brucellosis Vaccines Sales by Type
        4.1.1 Global Brucellosis Vaccines Historical Sales by Type (2017-2022)
        4.1.2 Global Brucellosis Vaccines Forecasted Sales by Type (2023-2028)
        4.1.3 Global Brucellosis Vaccines Sales Market Share by Type (2017-2028)
    4.2 Global Brucellosis Vaccines Revenue by Type
        4.2.1 Global Brucellosis Vaccines Historical Revenue by Type (2017-2022)
        4.2.2 Global Brucellosis Vaccines Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Brucellosis Vaccines Revenue Market Share by Type (2017-2028)
    4.3 Global Brucellosis Vaccines Price by Type
        4.3.1 Global Brucellosis Vaccines Price by Type (2017-2022)
        4.3.2 Global Brucellosis Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Brucellosis Vaccines Sales by Application
        5.1.1 Global Brucellosis Vaccines Historical Sales by Application (2017-2022)
        5.1.2 Global Brucellosis Vaccines Forecasted Sales by Application (2023-2028)
        5.1.3 Global Brucellosis Vaccines Sales Market Share by Application (2017-2028)
    5.2 Global Brucellosis Vaccines Revenue by Application
        5.2.1 Global Brucellosis Vaccines Historical Revenue by Application (2017-2022)
        5.2.2 Global Brucellosis Vaccines Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Brucellosis Vaccines Revenue Market Share by Application (2017-2028)
    5.3 Global Brucellosis Vaccines Price by Application
        5.3.1 Global Brucellosis Vaccines Price by Application (2017-2022)
        5.3.2 Global Brucellosis Vaccines Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Brucellosis Vaccines Market Size by Type
        6.1.1 North America Brucellosis Vaccines Sales by Type (2017-2028)
        6.1.2 North America Brucellosis Vaccines Revenue by Type (2017-2028)
    6.2 North America Brucellosis Vaccines Market Size by Application
        6.2.1 North America Brucellosis Vaccines Sales by Application (2017-2028)
        6.2.2 North America Brucellosis Vaccines Revenue by Application (2017-2028)
    6.3 North America Brucellosis Vaccines Market Size by Country
        6.3.1 North America Brucellosis Vaccines Sales by Country (2017-2028)
        6.3.2 North America Brucellosis Vaccines Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Brucellosis Vaccines Market Size by Type
        7.1.1 Europe Brucellosis Vaccines Sales by Type (2017-2028)
        7.1.2 Europe Brucellosis Vaccines Revenue by Type (2017-2028)
    7.2 Europe Brucellosis Vaccines Market Size by Application
        7.2.1 Europe Brucellosis Vaccines Sales by Application (2017-2028)
        7.2.2 Europe Brucellosis Vaccines Revenue by Application (2017-2028)
    7.3 Europe Brucellosis Vaccines Market Size by Country
        7.3.1 Europe Brucellosis Vaccines Sales by Country (2017-2028)
        7.3.2 Europe Brucellosis Vaccines Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Brucellosis Vaccines Market Size by Type
        8.1.1 Asia Pacific Brucellosis Vaccines Sales by Type (2017-2028)
        8.1.2 Asia Pacific Brucellosis Vaccines Revenue by Type (2017-2028)
    8.2 Asia Pacific Brucellosis Vaccines Market Size by Application
        8.2.1 Asia Pacific Brucellosis Vaccines Sales by Application (2017-2028)
        8.2.2 Asia Pacific Brucellosis Vaccines Revenue by Application (2017-2028)
    8.3 Asia Pacific Brucellosis Vaccines Market Size by Region
        8.3.1 Asia Pacific Brucellosis Vaccines Sales by Region (2017-2028)
        8.3.2 Asia Pacific Brucellosis Vaccines Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Brucellosis Vaccines Market Size by Type
        9.1.1 Latin America Brucellosis Vaccines Sales by Type (2017-2028)
        9.1.2 Latin America Brucellosis Vaccines Revenue by Type (2017-2028)
    9.2 Latin America Brucellosis Vaccines Market Size by Application
        9.2.1 Latin America Brucellosis Vaccines Sales by Application (2017-2028)
        9.2.2 Latin America Brucellosis Vaccines Revenue by Application (2017-2028)
    9.3 Latin America Brucellosis Vaccines Market Size by Country
        9.3.1 Latin America Brucellosis Vaccines Sales by Country (2017-2028)
        9.3.2 Latin America Brucellosis Vaccines Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Brucellosis Vaccines Market Size by Type
        10.1.1 Middle East and Africa Brucellosis Vaccines Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Brucellosis Vaccines Revenue by Type (2017-2028)
    10.2 Middle East and Africa Brucellosis Vaccines Market Size by Application
        10.2.1 Middle East and Africa Brucellosis Vaccines Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Brucellosis Vaccines Revenue by Application (2017-2028)
    10.3 Middle East and Africa Brucellosis Vaccines Market Size by Country
        10.3.1 Middle East and Africa Brucellosis Vaccines Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Brucellosis Vaccines Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Jinyu
        11.1.1 Jinyu Corporation Information
        11.1.2 Jinyu Overview
        11.1.3 Jinyu Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Jinyu Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Jinyu Recent Developments
    11.2 Colorado Serum
        11.2.1 Colorado Serum Corporation Information
        11.2.2 Colorado Serum Overview
        11.2.3 Colorado Serum Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Colorado Serum Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Colorado Serum Recent Developments
    11.3 Boehringer Ingelheim
        11.3.1 Boehringer Ingelheim Corporation Information
        11.3.2 Boehringer Ingelheim Overview
        11.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Boehringer Ingelheim Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Boehringer Ingelheim Recent Developments
    11.4 Biogenesis-Bago
        11.4.1 Biogenesis-Bago Corporation Information
        11.4.2 Biogenesis-Bago Overview
        11.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Biogenesis-Bago Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Biogenesis-Bago Recent Developments
    11.5 Vetal Company
        11.5.1 Vetal Company Corporation Information
        11.5.2 Vetal Company Overview
        11.5.3 Vetal Company Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Vetal Company Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Vetal Company Recent Developments
    11.6 CZ Veterinaria
        11.6.1 CZ Veterinaria Corporation Information
        11.6.2 CZ Veterinaria Overview
        11.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 CZ Veterinaria Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 CZ Veterinaria Recent Developments
    11.7 SYVA Laboratorios
        11.7.1 SYVA Laboratorios Corporation Information
        11.7.2 SYVA Laboratorios Overview
        11.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 SYVA Laboratorios Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 SYVA Laboratorios Recent Developments
    11.8 Indian Immunologicals
        11.8.1 Indian Immunologicals Corporation Information
        11.8.2 Indian Immunologicals Overview
        11.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Indian Immunologicals Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Indian Immunologicals Recent Developments
    11.9 Qilu
        11.9.1 Qilu Corporation Information
        11.9.2 Qilu Overview
        11.9.3 Qilu Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Qilu Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Qilu Recent Developments
    11.10 Tecnovax
        11.10.1 Tecnovax Corporation Information
        11.10.2 Tecnovax Overview
        11.10.3 Tecnovax Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Tecnovax Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Tecnovax Recent Developments
    11.11 Hester Biosciences
        11.11.1 Hester Biosciences Corporation Information
        11.11.2 Hester Biosciences Overview
        11.11.3 Hester Biosciences Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Hester Biosciences Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Hester Biosciences Recent Developments
    11.12 Zoetis
        11.12.1 Zoetis Corporation Information
        11.12.2 Zoetis Overview
        11.12.3 Zoetis Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Zoetis Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Zoetis Recent Developments
    11.13 Onderstepoort Biological
        11.13.1 Onderstepoort Biological Corporation Information
        11.13.2 Onderstepoort Biological Overview
        11.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Onderstepoort Biological Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Onderstepoort Biological Recent Developments
    11.14 Instituto Rosenbusch
        11.14.1 Instituto Rosenbusch Corporation Information
        11.14.2 Instituto Rosenbusch Overview
        11.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Instituto Rosenbusch Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Instituto Rosenbusch Recent Developments
    11.15 Ceva Sante Animale
        11.15.1 Ceva Sante Animale Corporation Information
        11.15.2 Ceva Sante Animale Overview
        11.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Ceva Sante Animale Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Ceva Sante Animale Recent Developments
    11.16 Calier & Biologicos Laverlam
        11.16.1 Calier & Biologicos Laverlam Corporation Information
        11.16.2 Calier & Biologicos Laverlam Overview
        11.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 Calier & Biologicos Laverlam Recent Developments
    11.17 Biovet
        11.17.1 Biovet Corporation Information
        11.17.2 Biovet Overview
        11.17.3 Biovet Brucellosis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.17.4 Biovet Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.17.5 Biovet Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Brucellosis Vaccines Industry Chain Analysis
    12.2 Brucellosis Vaccines Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Brucellosis Vaccines Production Mode & Process
    12.4 Brucellosis Vaccines Sales and Marketing
        12.4.1 Brucellosis Vaccines Sales Channels
        12.4.2 Brucellosis Vaccines Distributors
    12.5 Brucellosis Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Brucellosis Vaccines Industry Trends
    13.2 Brucellosis Vaccines Market Drivers
    13.3 Brucellosis Vaccines Market Challenges
    13.4 Brucellosis Vaccines Market Restraints
14 Key Findings in The Global Brucellosis Vaccines Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Brucellosis Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of S19 Vaccine
    Table 3. Major Manufacturers of RB51 Vaccine Strain
    Table 4. Global Brucellosis Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Brucellosis Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Brucellosis Vaccines Sales by Region (2017-2022) & (M Doses)
    Table 7. Global Brucellosis Vaccines Sales Market Share by Region (2017-2022)
    Table 8. Global Brucellosis Vaccines Sales by Region (2023-2028) & (M Doses)
    Table 9. Global Brucellosis Vaccines Sales Market Share by Region (2023-2028)
    Table 10. Global Brucellosis Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Brucellosis Vaccines Revenue Market Share by Region (2017-2022)
    Table 12. Global Brucellosis Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Brucellosis Vaccines Revenue Market Share by Region (2023-2028)
    Table 14. Global Brucellosis Vaccines Sales by Manufacturers (2017-2022) & (M Doses)
    Table 15. Global Brucellosis Vaccines Sales Share by Manufacturers (2017-2022)
    Table 16. Global Brucellosis Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Brucellosis Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 18. Brucellosis Vaccines Price by Manufacturers (2017-2022) &(USD/K Doses)
    Table 19. Global Brucellosis Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Brucellosis Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucellosis Vaccines as of 2021)
    Table 21. Brucellosis Vaccines Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Brucellosis Vaccines Product Offered
    Table 23. Date of Manufacturers Enter into Brucellosis Vaccines Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 26. Global Brucellosis Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 27. Global Brucellosis Vaccines Sales Share by Type (2017-2022)
    Table 28. Global Brucellosis Vaccines Sales Share by Type (2023-2028)
    Table 29. Global Brucellosis Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Brucellosis Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Brucellosis Vaccines Revenue Share by Type (2017-2022)
    Table 32. Global Brucellosis Vaccines Revenue Share by Type (2023-2028)
    Table 33. Brucellosis Vaccines Price by Type (2017-2022) & (USD/K Doses)
    Table 34. Global Brucellosis Vaccines Price Forecast by Type (2023-2028) & (USD/K Doses)
    Table 35. Global Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)
    Table 36. Global Brucellosis Vaccines Sales by Application (2023-2028) & (M Doses)
    Table 37. Global Brucellosis Vaccines Sales Share by Application (2017-2022)
    Table 38. Global Brucellosis Vaccines Sales Share by Application (2023-2028)
    Table 39. Global Brucellosis Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Brucellosis Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Brucellosis Vaccines Revenue Share by Application (2017-2022)
    Table 42. Global Brucellosis Vaccines Revenue Share by Application (2023-2028)
    Table 43. Brucellosis Vaccines Price by Application (2017-2022) & (USD/K Doses)
    Table 44. Global Brucellosis Vaccines Price Forecast by Application (2023-2028) & (USD/K Doses)
    Table 45. North America Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 46. North America Brucellosis Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 47. North America Brucellosis Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Brucellosis Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)
    Table 50. North America Brucellosis Vaccines Sales by Application (2023-2028) & (M Doses)
    Table 51. North America Brucellosis Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Brucellosis Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Brucellosis Vaccines Sales by Country (2017-2022) & (M Doses)
    Table 54. North America Brucellosis Vaccines Sales by Country (2023-2028) & (M Doses)
    Table 55. North America Brucellosis Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Brucellosis Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 58. Europe Brucellosis Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 59. Europe Brucellosis Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Brucellosis Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)
    Table 62. Europe Brucellosis Vaccines Sales by Application (2023-2028) & (M Doses)
    Table 63. Europe Brucellosis Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Brucellosis Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Brucellosis Vaccines Sales by Country (2017-2022) & (M Doses)
    Table 66. Europe Brucellosis Vaccines Sales by Country (2023-2028) & (M Doses)
    Table 67. Europe Brucellosis Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Brucellosis Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 70. Asia Pacific Brucellosis Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 71. Asia Pacific Brucellosis Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Brucellosis Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)
    Table 74. Asia Pacific Brucellosis Vaccines Sales by Application (2023-2028) & (M Doses)
    Table 75. Asia Pacific Brucellosis Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Brucellosis Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Brucellosis Vaccines Sales by Region (2017-2022) & (M Doses)
    Table 78. Asia Pacific Brucellosis Vaccines Sales by Region (2023-2028) & (M Doses)
    Table 79. Asia Pacific Brucellosis Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Brucellosis Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 82. Latin America Brucellosis Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 83. Latin America Brucellosis Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Brucellosis Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)
    Table 86. Latin America Brucellosis Vaccines Sales by Application (2023-2028) & (M Doses)
    Table 87. Latin America Brucellosis Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Brucellosis Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Brucellosis Vaccines Sales by Country (2017-2022) & (M Doses)
    Table 90. Latin America Brucellosis Vaccines Sales by Country (2023-2028) & (M Doses)
    Table 91. Latin America Brucellosis Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Brucellosis Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 94. Middle East and Africa Brucellosis Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 95. Middle East and Africa Brucellosis Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Brucellosis Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)
    Table 98. Middle East and Africa Brucellosis Vaccines Sales by Application (2023-2028) & (M Doses)
    Table 99. Middle East and Africa Brucellosis Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Brucellosis Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Brucellosis Vaccines Sales by Country (2017-2022) & (M Doses)
    Table 102. Middle East and Africa Brucellosis Vaccines Sales by Country (2023-2028) & (M Doses)
    Table 103. Middle East and Africa Brucellosis Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Brucellosis Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Jinyu Corporation Information
    Table 106. Jinyu Description and Major Businesses
    Table 107. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 108. Jinyu Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Jinyu Recent Developments
    Table 110. Colorado Serum Corporation Information
    Table 111. Colorado Serum Description and Major Businesses
    Table 112. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 113. Colorado Serum Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Colorado Serum Recent Developments
    Table 115. Boehringer Ingelheim Corporation Information
    Table 116. Boehringer Ingelheim Description and Major Businesses
    Table 117. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 118. Boehringer Ingelheim Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Boehringer Ingelheim Recent Developments
    Table 120. Biogenesis-Bago Corporation Information
    Table 121. Biogenesis-Bago Description and Major Businesses
    Table 122. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 123. Biogenesis-Bago Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Biogenesis-Bago Recent Developments
    Table 125. Vetal Company Corporation Information
    Table 126. Vetal Company Description and Major Businesses
    Table 127. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 128. Vetal Company Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Vetal Company Recent Developments
    Table 130. CZ Veterinaria Corporation Information
    Table 131. CZ Veterinaria Description and Major Businesses
    Table 132. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 133. CZ Veterinaria Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. CZ Veterinaria Recent Developments
    Table 135. SYVA Laboratorios Corporation Information
    Table 136. SYVA Laboratorios Description and Major Businesses
    Table 137. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 138. SYVA Laboratorios Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. SYVA Laboratorios Recent Developments
    Table 140. Indian Immunologicals Corporation Information
    Table 141. Indian Immunologicals Description and Major Businesses
    Table 142. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 143. Indian Immunologicals Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Indian Immunologicals Recent Developments
    Table 145. Qilu Corporation Information
    Table 146. Qilu Description and Major Businesses
    Table 147. Qilu Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 148. Qilu Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Qilu Recent Developments
    Table 150. Tecnovax Corporation Information
    Table 151. Tecnovax Description and Major Businesses
    Table 152. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 153. Tecnovax Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Tecnovax Recent Developments
    Table 155. Hester Biosciences Corporation Information
    Table 156. Hester Biosciences Description and Major Businesses
    Table 157. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 158. Hester Biosciences Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Hester Biosciences Recent Developments
    Table 160. Zoetis Corporation Information
    Table 161. Zoetis Description and Major Businesses
    Table 162. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 163. Zoetis Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Zoetis Recent Developments
    Table 165. Onderstepoort Biological Corporation Information
    Table 166. Onderstepoort Biological Description and Major Businesses
    Table 167. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 168. Onderstepoort Biological Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Onderstepoort Biological Recent Developments
    Table 170. Instituto Rosenbusch Corporation Information
    Table 171. Instituto Rosenbusch Description and Major Businesses
    Table 172. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 173. Instituto Rosenbusch Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. Instituto Rosenbusch Recent Developments
    Table 175. Ceva Sante Animale Corporation Information
    Table 176. Ceva Sante Animale Description and Major Businesses
    Table 177. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 178. Ceva Sante Animale Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 179. Ceva Sante Animale Recent Developments
    Table 180. Calier & Biologicos Laverlam Corporation Information
    Table 181. Calier & Biologicos Laverlam Description and Major Businesses
    Table 182. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 183. Calier & Biologicos Laverlam Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 184. Calier & Biologicos Laverlam Recent Developments
    Table 185. Biovet Corporation Information
    Table 186. Biovet Description and Major Businesses
    Table 187. Biovet Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 188. Biovet Brucellosis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 189. Biovet Recent Developments
    Table 190. Key Raw Materials Lists
    Table 191. Raw Materials Key Suppliers Lists
    Table 192. Brucellosis Vaccines Distributors List
    Table 193. Brucellosis Vaccines Customers List
    Table 194. Brucellosis Vaccines Market Trends
    Table 195. Brucellosis Vaccines Market Drivers
    Table 196. Brucellosis Vaccines Market Challenges
    Table 197. Brucellosis Vaccines Market Restraints
    Table 198. Research Programs/Design for This Report
    Table 199. Key Data Information from Secondary Sources
    Table 200. Key Data Information from Primary Sources
List of Figures
    Figure 1. Brucellosis Vaccines Product Picture
    Figure 3. Global Brucellosis Vaccines Market Share by Type in 2021 & 2028
    Figure 3. S19 Vaccine Product Picture
    Figure 4. RB51 Vaccine Strain Product Picture
    Figure 5. Global Brucellosis Vaccines Market Share by Application in 2021 & 2028
    Figure 6. Cattle
    Figure 7. Sheep
    Figure 8. Others
    Figure 9. Brucellosis Vaccines Report Years Considered
    Figure 10. Global Brucellosis Vaccines Sales 2017-2028 (M Doses)
    Figure 11. Global Brucellosis Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Brucellosis Vaccines Revenue 2017-2028 (US$ Million)
    Figure 13. Global Brucellosis Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Brucellosis Vaccines Sales Market Share by Region (2017-2022)
    Figure 15. Global Brucellosis Vaccines Sales Market Share by Region (2023-2028)
    Figure 16. North America Brucellosis Vaccines Sales YoY (2017-2028) & (M Doses)
    Figure 17. North America Brucellosis Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Brucellosis Vaccines Sales YoY (2017-2028) & (M Doses)
    Figure 19. Europe Brucellosis Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Brucellosis Vaccines Sales YoY (2017-2028) & (M Doses)
    Figure 21. Asia-Pacific Brucellosis Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Brucellosis Vaccines Sales YoY (2017-2028) & (M Doses)
    Figure 23. Latin America Brucellosis Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Brucellosis Vaccines Sales YoY (2017-2028) & (M Doses)
    Figure 25. Middle East & Africa Brucellosis Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Brucellosis Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Brucellosis Vaccines in the World: Market Share by Brucellosis Vaccines Revenue in 2021
    Figure 28. Global Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Brucellosis Vaccines Sales Market Share by Type (2017-2028)
    Figure 30. Global Brucellosis Vaccines Revenue Market Share by Type (2017-2028)
    Figure 31. Global Brucellosis Vaccines Sales Market Share by Application (2017-2028)
    Figure 32. Global Brucellosis Vaccines Revenue Market Share by Application (2017-2028)
    Figure 33. North America Brucellosis Vaccines Sales Market Share by Type (2017-2028)
    Figure 34. North America Brucellosis Vaccines Revenue Market Share by Type (2017-2028)
    Figure 35. North America Brucellosis Vaccines Sales Market Share by Application (2017-2028)
    Figure 36. North America Brucellosis Vaccines Revenue Market Share by Application (2017-2028)
    Figure 37. North America Brucellosis Vaccines Sales Share by Country (2017-2028)
    Figure 38. North America Brucellosis Vaccines Revenue Share by Country (2017-2028)
    Figure 39. U.S. Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Brucellosis Vaccines Sales Market Share by Type (2017-2028)
    Figure 42. Europe Brucellosis Vaccines Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Brucellosis Vaccines Sales Market Share by Application (2017-2028)
    Figure 44. Europe Brucellosis Vaccines Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Brucellosis Vaccines Sales Share by Country (2017-2028)
    Figure 46. Europe Brucellosis Vaccines Revenue Share by Country (2017-2028)
    Figure 47. Germany Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 48. France Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Brucellosis Vaccines Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Brucellosis Vaccines Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Brucellosis Vaccines Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Brucellosis Vaccines Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Brucellosis Vaccines Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Brucellosis Vaccines Revenue Share by Region (2017-2028)
    Figure 58. China Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 61. India Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 63. China Taiwan Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Brucellosis Vaccines Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Brucellosis Vaccines Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Brucellosis Vaccines Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Brucellosis Vaccines Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Brucellosis Vaccines Sales Share by Country (2017-2028)
    Figure 72. Latin America Brucellosis Vaccines Revenue Share by Country (2017-2028)
    Figure 73. Mexico Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Brucellosis Vaccines Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Brucellosis Vaccines Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Brucellosis Vaccines Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Brucellosis Vaccines Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Brucellosis Vaccines Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Brucellosis Vaccines Revenue Share by Country (2017-2028)
    Figure 82. Turkey Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 84. UAE Brucellosis Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 85. Brucellosis Vaccines Value Chain
    Figure 86. Brucellosis Vaccines Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Jinyu
Colorado Serum
Boehringer Ingelheim
Biogenesis-Bago
Vetal Company
CZ Veterinaria
SYVA Laboratorios
Indian Immunologicals
Qilu
Tecnovax
Hester Biosciences
Zoetis
Onderstepoort Biological
Instituto Rosenbusch
Ceva Sante Animale
Calier & Biologicos Laverlam
Biovet
Frequently Asked Questions
Brucellosis Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Brucellosis Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Brucellosis Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Cryocoolers

Cryocoolers market is segmented by Type and by Application. Players, stakeholders, and other part ... Read More

L-Lysine

L-Lysine market is segmented by Type and by Application. Players, stakeholders, and other partici ... Read More